However, there is an approximately 10-fold increase in the Kp in the tumor rim and normal brain regions and a 4-fold increase in Kp in the tumor core when elacridar is co-administered with ispinesib (Fig. 4E). The gene discussed is NPPA; the disease is neoplasm.